相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Yojiro Hashiguchi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
Shinji Matsutani et al.
CANCER SCIENCE (2018)
Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations
Keiichi Hatakeyama et al.
SCIENTIFIC REPORTS (2018)
Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse
Tadashi Ashizawa et al.
CLINICAL CANCER RESEARCH (2017)
Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer
Xiaomei Gong et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE2/β-catenin signalling pathway
Dehai Che et al.
MOLECULAR IMMUNOLOGY (2017)
Robotic-assisted multivisceral resection for rectal cancer: short-term outcomes at a single center
H. Hino et al.
TECHNIQUES IN COLOPROCTOLOGY (2017)
Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplificationdependent overexpression in 1,454 solid tumors
Keiichi Ohshima et al.
SCIENTIFIC REPORTS (2017)
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Rodrigo Dienstmann et al.
NATURE REVIEWS CANCER (2017)
Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer
Joana Tato-Costa et al.
CLINICAL COLORECTAL CANCER (2016)
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
Yanhong Deng et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer
Li-Ching Fan et al.
ONCOTARGET (2016)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2015)
Stromal contribution to the colorectal cancer transcriptome
Claudio Isella et al.
NATURE GENETICS (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells
Jing Guo et al.
ONCOLOGY REPORTS (2015)
SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data
Zhongyang Zhang et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Image Analyzer-Based Assessment of Tumor-Infiltrating T Cell Subsets and Their Prognostic Values in Colorectal Carcinomas
Younghoon Kim et al.
PLoS One (2015)
CD8+and FOXP3+Tumor-Infiltrating T Cells Before and After Chemoradiotherapy for Rectal Cancer
Eiji Shinto et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer
V. J. Findlay et al.
CANCER GENE THERAPY (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Alexandre Calon et al.
CANCER CELL (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Ralf-Dieter Hofheinz et al.
LANCET ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy
Aneel Bhangu et al.
SURGICAL ONCOLOGY-OXFORD (2012)
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
Vincenzo Valentini et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
Anna M. Dahlin et al.
MODERN PATHOLOGY (2011)
Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)